Filing Details

Accession Number:
0001127602-18-011394
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-13 16:43:22
Reporting Period:
2018-03-13
Accepted Time:
2018-03-13 16:43:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374175 Paul Herendeen 400 Somerset Corporate Boulevard
Bridgewater NJ 08807
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2018-03-13 15,000 $16.10 231,492 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually paid in this transaction range from $16.09 to $16.10 per Common Share.
  2. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range reported above.